Please login to the form below
depression
This page shows the latest depression news and features for those working in and with pharma, biotech and healthcare.
New data keeps AbbVie’s star pipeline therapies on track
There were also significant improvements for AbbVie’s drug over Humira on quality of life measures and over Stelara on anxiety and depression, and risankizumab did better than both comparator drugs
Latest news
-
Daily Brief: another departure at Gilead, veteran researcher to head Karuna
Steven Paul, a veteran researcher who played a key role in developing Lilly’s antipsychotic and depression blockbuster drugs such as Zyprexa and Cymbalta is to head up efforts to find
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
researchers’time). Many of the proposed projects address brain disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, major depression, and immune-mediated diseases such as Crohn’s
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
researchers’time). Many of the proposed projects address brain disorders, such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, major depression, and immune-mediated diseases such as Crohn’s
-
Sage surges after depression drug gets rapid path to approval
Sage surges after depression drug gets rapid path to approval. Will be able to file a marketing application based on its phase II trial. ... The FDA has given its blessing to an expedited development route for Sage Therapeutics’depression pill SAGE-217,
-
Daily Brief
With about 30% of patients with major depression failing to respond to currently available antidepressants1, treatment-resistant depression represents a major public health need," said Husseini K. ... Esketamine received Breakthrough Therapy Designations
More from news
Approximately 22 fully matching, plus 312 partially matching documents found.
Latest Intelligence
-
Health on instalment
The real estate collapse sparked by the Great Depression inspired the US to invent the 30-year mortgage. ... But the Depression annihilated all that refinance money overnight, leaving millions in the lurch.
-
Speech therapy
The first of these studies looked at ‘Woebot’, a Facebook Messenger bot delivering text-based cognitive behavioural therapy, which successfully reduced self-reported symptoms of depression in its users.
-
Finding the patient voice
With chronic conditions (15%) or fighting mental illness like depression (12%), most of them hope to find a permanent solution by joining a trial.
-
Reading human behaviour to create a medical future
series of cue cards to enable them to talk about difficult topics such as alcohol consumption and depression - which are key to their treatment yet often overlooked - with their physicians, and
-
Here’s to all the bright sparks
Or marketing revolutionary total knee replacements to defining new cures for depression… The future of healthcare is a wonderful place.
More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.
Latest appointments
-
Clark Health Communications expands team
responsible for driving the delivery of CHC’s gastroenterology, women’s health, depression and anticoagulants business.
-
Dr Niall Murphy and Pierre Schwich join Pharnext
Prior to this, Dr Murphy served as a unit leader for a team of scientists collaborating on research in the areas of addition biology, Alzheimer's disease, anxiety, depression and neurotoxicity
-
Turing names Eliseo Salinas as head of R&D
Salinas has played a leading role in numerous programmes for a range of diseases and disorders, with specific focus on central nervous systems (CNS) condition such as depression and anxiety, schizophrenia,
-
Lundbeck promotes Andreas Eggert and Klaus Abel to senior commercial roles
vortioxetine for major depression and Selincro (nalmefene) for alcohol dependence. ... including a once-monthly aripiprazole formulation for the treatment of schizophrenia and brexpiprazole (OPC-34712) for the treatment of schizophrenia and major
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Mental health in the workplace
Managing mental health conditions (such as stress, anxiety, depression and obsessive– compulsive disorder) remains a challenge, despite the recent efforts of many companies to implement policies to support a healthy workforce.
-
AN ADVOCACY Rx FOR PROGRESS IN MENTAL HEALTH
there’ s an abundance of smart thinking on how to improve the lives of people who struggle with major depression, schizophrenia, bipolar disorder, and other serious conditions.
-
Mental Health Patient Advocacy Groups in EU Say Strong Partnerships with Government and Industry Can Ensure Forward Progress
2 Six out of the 20 countries with the highest suicide rates in the world are in the European Region2 and in many EU Member States, depression is already the most ... Last accessed 8 January 2017. 3 European Depression Association Depression Manifesto: A
-
Clark Health Communications named Small Consultancy of the Year
and explore a specific population of depression patients; those who only partially respond to their medication.
-
How can pharma help the NHS drive much-needed change in mental health services?
million people will have dementia by 2021.However, despite the prevalence of mental health problems, only a quarter of people with illnesses, such as depression, are receiving treatment, according to NHS ... week programme designed for people with
More from PMHub
Approximately 4 fully matching, plus 24 partially matching documents found.
Featured jobs
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
-
Associate Scientific Director
-
Salary TBC
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Senior Medical Writer
-
Salary is DOE
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
-
Systematic Review Lead- London
-
Negotiable
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Account Director or Senior Account Director
-
Salary TBC
- Senior Writer, Healthcare Advertising, London
-
Excellent package
Subscribe to our email news alerts
- Moving annual total (MAT)
- AZ prepares to file COPD triple, taking on rival GSK
- J&J files ‘breakthrough’ bladder cancer drug in US
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Teva wins FDA OK for crucial migraine drug
- NHS wins legal fight with pharma over off-label Avastin
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
